Dennis Karl Huang

Insider Reports History

Location
Novato, CA
Signature
/s/ Karah Parschauer, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dennis Karl Huang:

Company Role Class Num Shares Value Price $ Report Date Ownership
Ultragenyx Pharmaceutical Inc. EVP, Chief Technical Operations Officer Common Stock 124,729 $2,917,411 $23.39 02 Mar 2026 Direct
Ultragenyx Pharmaceutical Inc. EVP, Chief Technical Operations Officer Stock Option (Right to Buy) 26,074 01 Mar 2025 Direct

Insider Reports Filed by Dennis Karl Huang

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RARE Ultragenyx Pharmaceutical Inc. 01 Mar 2026 2 -$23,367 4 EVP, Chief Technical Operations Officer 03 Mar 2026, 18:49
RARE Ultragenyx Pharmaceutical Inc. 01 Mar 2025 4 -$57,856 4 Officer 04 Mar 2025, 20:02
RARE Ultragenyx Pharmaceutical Inc. 01 Mar 2024 4 -$25,234 4 EVP, Chief Technical Operations Officer 05 Mar 2024, 20:17
RARE Ultragenyx Pharmaceutical Inc. 01 Mar 2023 5 -$501,602 4 EVP, Chief Technical Operations Officer 03 Mar 2023, 18:53
RARE Ultragenyx Pharmaceutical Inc. 01 Mar 2022 3 -$215,449 4 EVP, Chief Technical Operations Officer and Gene Therapy Operations 03 Mar 2022, 17:09
RARE Ultragenyx Pharmaceutical Inc. 14 Oct 2021 1 -$29,048 4 EVP & Chief Tech Ops Officer 18 Oct 2021, 18:55
RARE Ultragenyx Pharmaceutical Inc. 06 May 2021 1 -$41,266 4 EVP & Chief Tech Ops Officer 10 May 2021, 18:14